Symposium May 2011
Frontiers in tumor immunology: Innovative Immunotherapies ; May 02 - 03, 2011
Dear Colleagues,
We would like to thank all participants for coming to our first meeting on Frontiers in Tumor Immunology: Innovative Immunotherapies that was held at the beginning of May in Tübingen. So far the resonance from those attending the meeting has been extremely positive. Therefore, we consider to organize similar events every two years in future. We hope that we will meet all of you again at our next conference.
Invited Speaker
- Kamran Ghoreschi, Bethesda, U.S.A.
- Wolf Hervé Fridman, Paris, France
- Francesca Di Rosa, Rome, Italy
- Tomasz Zal, Houston, U.S.A.
- Jörg Wischhusen, Würzburg, Germany
- Andrea Schietinger, Seattle, U.S.A.
- Patrick Baeuerle, Micromet, München
- Christoph A. Klein, Regensburg, Germany
- Harpreet Singh, immatics, Tübingen
- Birgit Scheel, CureVac, Tübingen
- Taha Merghoub, New York, U.S.A.
- Cornelis J.M. Melief, The Netherlands
- Gerold Schuler, Erlangen, Germany
- Martin Röcken, Tübingen, Germany
- Dolores Schendel, München, Germany
- Max Topp, Würzburg, Germany
- Gundram Jung, Tübingen, Germany
- Rupert Handgretinger, Tübingen, Germany
- Hans-Georg Rammensee, Chair
- Gert Riethmüller, Co-Chair
